https://pmlive.com/digital_edition/pme_supplements/diversity_equity_and_inclusion_1451077/
Diversity, equity and inclusion - PMLiVE
Diversity, equity and inclusion in the workplace
diversity equityinclusion
https://pmlive.com/register-for-a-pmhub-account/
Register for a PMHub account - PMLiVE
Feb 8, 2024 - Adding your company profile to PMHub is a simple process.
registeraccountpmlive
https://pmlive.com/digital_edition/communique/communique_-_volume_53/
Communiqué - Volume 53 - PMLiVE
New insights in health comms innovation. Communiqué Awards 2022 – winners’ case studies. INSIGHTS – Demonstrating impact • Driving behaviour change
volumepmlive
https://pmlive.com/intelligence/optimised-therapy-to-improve-outcomes-for-heart-attack-and-stroke-patients/
Optimised therapy to improve outcomes for heart attack and stroke patients - PMLiVE
Dec 4, 2025 - Personalising therapy promises to revolutionise the treatment of thrombosis
improve outcomesheart attack
https://pmlive.com/pharma_news/regenerons-libtayo-receives-ec-approval-for-skin-cancer/
Regeneron’s Libtayo receives EC approval for skin cancer - PMLiVE
Nov 28, 2025 - Phase 3 trial results showed the drug significantly improved disease-free survival
skin cancerreceivesapproval
https://pmlive.com/pharma_news/tonix-launches-new-oral-fibromyalgia-treatment/
Tonix launches new oral fibromyalgia treatment - PMLiVE
Nov 27, 2025 - Tonmya is the first approved treatment for adults with fibromyalgia in over 15 years
launches newtreatment pmlive
https://pmlive.com/intelligence/a-new-advent-of-clinical-pathway-management/
A new advent of clinical pathway management - PMLiVE
Nov 6, 2025 - Platelet functionality analysis could pave the way to improving drug asset selection and de-risking clinical trials
newadventclinicalpathway
https://pmlive.com/intelligence/genai-tools-creating-a-new-era-of-scientific-research/
GenAI tools – creating a new era of scientific research - PMLiVE
Nov 12, 2025 - The new wave of GenAI-powered search tools now offers researchers an alternative method for accessing insights at speed
genai toolsnew eracreating
https://pmlive.com/
PMLiVE | Pharmaceutical industry news, articles, jobs, reports, advice and services
pharmaceutical industrypmlive
https://pmlive.com/intelligence/esmo-2025-ensuring-innovation-isnt-lost-in-translation/
ESMO 2025 – ensuring innovation isn’t lost in translation - PMLiVE
Nov 28, 2025 - This year marks the congress’s 50th anniversary, with the theme: Many journeys. One global community
esmoensuringinnovationlost
https://pmlive.com/pharma_news/sandoz-launches-first-and-only-multiple-sclerosis-biosimilar-in-us/
Sandoz launches first and only multiple sclerosis biosimilar in US - PMLiVE
Nov 27, 2025 - The treatment is FDA-approved to treat MS and Crohn’s disease
launches firstsandozmultiple
https://pmlive.com/intelligence/from-disruption-to-resilience-indias-growing-role-in-pharma-logistics/
From disruption to resilience: India’s growing role in pharma logistics - PMLiVE
Nov 10, 2025 - In light of US tariffs, India’s role as a politically neutral, cost-efficient partner is more critical than ever
growing rolepharma logistics
https://pmlive.com/pharma_news/bms-takeda-and-astex-join-ai-training-consortium/
BMS, Takeda and Astex join AI training consortium - PMLiVE
Oct 2, 2025 - The initiative focuses on training AI models to aid in drug discovery and development
ai trainingbmstakedaastexjoin
https://pmlive.com/pharma_news/novartis-itvisma-gets-fda-approval-for-spinal-muscular-atrophy-treatment/
Novartis’ Itvisma gets FDA approval for spinal muscular atrophy treatment - PMLiVE
Nov 28, 2025 - Around 9,000 people in the US currently live with SMA
spinal muscular atrophygets